Sanctions

A 10% tariff on aluminum windows forces Tecnoglass to cut its 2026 earnings outlook, signaling rising costs for the U.S. construction industry.

A landmark Supreme Court decision unlocked billions in tariff refunds for U.S. importers, but 90% of firms have yet to act. Are they leaving money on the table?

A federal trade body found that a surge in foreign imports is harming U.S. quartz manufacturers, setting the stage for potential presidential action.

With a fresh $17.3M, AI firm Sigma360 is escalating its fight against financial crime, tackling a $300B market with tech born from counterterrorism.

Over 4,000 figures, including Garry Kasparov, protest Russia's Biennale return, questioning the art world's ethical stance amid the war in Ukraine.

A ceremony in Halifax will honour Canada’s Gulf War veterans as the government formally recognizes the long-term health impacts of their service.

A new report finds 98% of firms use AI for fraud prevention, yet 94% are hiring more staff. The reason? Fragmented systems are winning the war.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

The Canadian restaurant giant defied a tough market in 2025, posting record sales and boosting investor payouts through strategic promotions and delivery.

A mechanics union has secured a new contract but now faces a new battle, vowing to protect jobs and safety standards as two major airlines plan to merge.

Amid rising global threats, Windward's new intelligence center uses agentic AI to transform maritime security from passive monitoring to active defense.

A new deal for the rare isotope Actinium-225 could break a major supply bottleneck, accelerating the development of highly targeted cancer treatments.

Facing intense scrutiny over product safety, e-commerce giant Temu partners with DEKRA in a multi-million dollar push to clean up its marketplace.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

A national report card gives the U.S. a 'B' on rare disease policy, but stark state-by-state disparities leave millions vulnerable to financial ruin.

EMD Serono and the Trump Administration launch a new program offering massive discounts on IVF drugs, bringing hope to millions of aspiring parents.

A new business coalition forms to protect NYC's Israeli tech sector, citing hostile policy shifts and rising antisemitism that threaten a vital economic engine.

After a four-year campaign, the World Health Organization is poised to recognize a silent liver epidemic, setting the stage for a new global NCD strategy.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

A new initiative from the Center for Educational Innovation aims to tackle the workforce readiness gap with AI, robotics, and teacher leadership training.